The Purpose Of This Assignment Is To Familiarize The Student ✓ Solved

The purpose of this assignment is to familiarize the student

The purpose of this assignment is to familiarize the student with the most recent guidelines and recommendations for vaccine-preventable illnesses in the United States.

Through this assignment, the student will demonstrate the ability to: 1. Identify vaccines available in the US market for vaccine-preventable disease and describe their features. 2. Identify contraindications and precautions for the use of vaccines available. 3. Use recommendations from the Advisory Committee on Immunization Practices (ACIP) to identify target groups for receipt of each vaccine.

Vaccination schedules should be obtained directly from the Centers for Disease Control and Prevention: Resources for Healthcare Providers website and reflect the most current recommendations from the Advisory Committee on Immunization Practices (ACIP). Additional scholarly resources should be used and all sources must be cited appropriately.

Choose 2 vaccines from the list provided and provide the following information for each: 1. Name of disease preventable vaccination 2. Trade name 3. Type of vaccination (attenuated or inactivated) 4. Contraindications 5. Precautions 6. Adverse drug reactions 7. Minimum age to receive vaccine 8. Routine recommended vaccine schedule (timing and dose) 9. Special situations.

Barriers & Interventions include identifying one reason for vaccine non-compliance or vaccine hesitancy by patients/parents, discussing one intervention that Nurse Practitioners can take to improve vaccination compliance, identifying when healthcare providers are required by law to report an adverse event, discussing adverse events that healthcare providers are encouraged to report, and identifying how a healthcare provider would report an adverse event.

Paper For Above Instructions

Vaccines are crucial public health tools that have significantly reduced the incidence of infectious diseases. This paper aims to provide an in-depth look into two vaccines from the list of vaccine-preventable diseases identified by the Centers for Disease Control and Prevention (CDC), namely the Diphtheria, Tetanus, and Pertussis (DTaP) vaccine and the Human Papillomavirus (HPV) vaccine. The information will include crucial aspects such as trade names, types of vaccines, contraindications, precautions, adverse drug reactions, minimum ages for administration, recommended vaccination schedules, and special situations associated with each vaccine.

Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine

1. Name of Disease Preventable Vaccination: Diphtheria, Tetanus, and Pertussis.

2. Trade Name: Daptacel.

3. Type of Vaccination: Inactivated.

4. Contraindications: The DTaP vaccine should not be administered to individuals with a history of severe allergic reactions after a previous dose or to any components of the vaccine. Additionally, it should be contraindicated for those who developed encephalopathy within seven days of vaccination or have a progressive neurological disorder.

5. Precautions: While DTaP is generally safe, it should be used with caution in patients with moderate to severe acute illness, a history of seizures, or those with Guillain-Barré syndrome (GBS) within six weeks following a previous vaccine.

6. Adverse Drug Reactions: Common adverse reactions include redness or swelling at the injection site, fever, irritability, loss of appetite, and drowsiness. Serious adverse reactions are rare but can include seizures and allergic reactions.

7. Minimum Age to Receive Vaccine: The DTaP vaccine can be administered as early as six weeks of age.

8. Routine Recommended Vaccine Schedule: The recommended schedule is a five-dose series at 2, 4, 6, and 15-18 months of age, and a booster dose between 4-6 years of age.

9. Special Situations: Special considerations include administration in children with a family history of seizures or those who may require hospitalization due to severe adverse reactions to previous vaccinations.

Human Papillomavirus (HPV) Vaccine

1. Name of Disease Preventable Vaccination: Human Papillomavirus.

2. Trade Name: Gardasil 9.

3. Type of Vaccination: Inactivated.

4. Contraindications: The HPV vaccine is contraindicated in individuals who have experienced a severe allergic reaction to any component of the vaccine, including yeasts. It should also not be given to pregnant women.

5. Precautions: Caution is advised for those with moderate to severe acute illnesses, although mild illnesses only should not prevent vaccination.

6. Adverse Drug Reactions: Common side effects include injection site reactions, headaches, and nausea. More severe adverse events, although rare, can include fainting, dizziness, or allergic reactions.

7. Minimum Age to Receive Vaccine: The HPV vaccine is recommended for adolescents starting at ages 11-12, but it can be given as early as 9 years old.

8. Routine Recommended Vaccine Schedule: The vaccine is typically administered as a two-dose series for those starting before their 15th birthday (at 0 and 6-12 months) or a three-dose series for those starting at age 15 or older (at 0, 1-2 months, and 6 months).

9. Special Situations: The HPV vaccine is recommended for those who are immunocompromised or have a history of sexually transmitted infections, as these individuals are at higher risk for HPV-related diseases.

Barriers and Interventions

One major barrier to vaccine compliance is the prevalence of vaccine hesitancy among parents, often influenced by misinformation regarding vaccine safety and effectiveness. Healthcare providers can combat this hesitancy by providing comprehensive education about the benefits of vaccines and addressing common concerns directly. This two-way communication fosters trust and reassures parents of the importance of vaccinations for public health.

Healthcare providers are legally required to report adverse events associated with vaccinations when they seriously affect a person's health; this requirement aims to enhance vaccine safety monitoring systems. They are encouraged to report events that don’t necessarily lead to serious health outcomes but contribute to understanding vaccine responses better.

To report adverse events, healthcare providers typically utilize the Vaccine Adverse Event Reporting System (VAERS), an established federal program that collects and analyzes data on vaccine adverse effects to ensure ongoing safety evaluations.

Conclusion

Understanding vaccines, their importance, and the contexts surrounding their use is crucial for every healthcare professional, particularly Nurse Practitioners. By being well-informed about vaccine recommendations, contraindications, and the impact of vaccine hesitancy, they can effectively advocate for vaccination among their patients and contribute to public health initiatives aimed at reducing vaccine-preventable diseases.

References

  • Centers for Disease Control and Prevention. (2021). Immunization schedules. Retrieved from https://www.cdc.gov/vaccines/schedules/index.html
  • World Health Organization. (2022). Vaccines and immunization. Retrieved from https://www.who.int/topics/vaccines/en/
  • American Academy of Pediatrics. (2020). Red Book: 2020 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: AAP.
  • National Institutes of Health. (2020). Vaccine Safety. Retrieved from https://www.niaid.nih.gov/research/vaccine-safety
  • Gonzalez, A., & Embi, P. J. (2021). Vaccine hesitancy: Why are parents refusing vaccines? Current Immunization Reports, 6(4), 12-22.
  • Orenstein, W. A., & Ahmed, F. (2020). The vaccination programs in the United States: Implications for vaccine delivery. Health Affairs, 39(4), 1-8.
  • Destefano, F., & Shimabukuro, T. (2019). Vaccines for adults: Trends, challenges, and the way forward. Journal of the American Medical Association, 321(12), 1103-1104.
  • U.S. Department of Health & Human Services. (2019). Vaccination coverage among children in the United States. National Immunization Survey. Retrieved from https://www.cdc.gov/vaccines/imz-resources/coverage.htm
  • Orenstein, W. A., & Wexler, M. (2021). History of vaccines in the United States. Infectious Disease Clinics of North America, 35(3), 373-389.
  • Shapiro, G. K., & Tuchin, V. (2020). Interventions to increase vaccine uptake in children and adolescents. The Lancet Child & Adolescent Health, 4(9), 712-711.

Related Assignments